C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2001
11/14/2001	EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001	EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001	EP0885212B1 Quinoxalinediones
11/14/2001	EP0828721B1 2-amino-benzoxazinones for the treatment of viral infections
11/14/2001	EP0801700B1 Use of optically brightened plastics for optically brightening paper-coating compounds and paper-coating compounds optically brightened in this manner
11/14/2001	CN1322204A Oxazolidinone antibacterial agents having thiocarbonyl functionality
11/14/2001	CN1322203A Heterocyclyl amino methyloxazolidinones as antibacterials
11/14/2001	CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322133A Vitronectin receptor antagonists
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1074764C Benzoxazinone dopamine D4 receptor antagonists
11/13/2001	US6316635 Used in prophylaxis and therapy of protein kinase related cellular disorders such as cancer, diabetes, autoimmune disorder, hyperproliferation disorder, inflammatory disorder, angiogenesis, restenosis, fibrosis, psoriasis, osteoarthritis
11/13/2001	US6316630 Treating epothilone to deoxygenate the epothilone, and thereby to provide the desoxyepothilone
11/13/2001	US6316625 Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
11/13/2001	US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001	US6316494 For therapy and prophylaxis of bone loss, osteoporosis, cardiovascular diseases, cognitive disorders, menopausal symptoms, incontinence, obesity, dysmenorrhea, dysfunctional uterine bleeding, acne, hirsutism, post-partum lactation
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316479 Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
11/13/2001	US6316477 Arylpyrazole insecticides
11/13/2001	US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001	US6316444 SRC kinase inhibitor compounds
11/08/2001	WO2001083800A2 Heterologous production of polyketides
11/08/2001	WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	WO2001083474A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
11/08/2001	WO2001083472A1 Muscarinic agonists
11/08/2001	WO2001083462A1 Novel, slow-acting betamimetics, a method for their production and their use as medicaments
11/08/2001	WO2001083460A1 Cyclic compounds
11/08/2001	WO2001040220A3 3-(4,5-dihydroisoxazol-3-yl)-substituted benzoylpyrazoles as herbicides
11/08/2001	WO2001029012A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001	WO2001029011A3 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
11/08/2001	US20010039352 Production method of isoxazolidinedione compound
11/08/2001	US20010039343 Pesticides, fungicides, herbicides, insecticides, microbiocdes, drugs
11/08/2001	US20010039289 Antagonists; especially sodium salts
11/08/2001	US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001	CA2407594A1 Muscarinic agonists
11/08/2001	CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	CA2407231A1 Cyclic compounds
11/08/2001	CA2405745A1 New betamimetics having a long-lasting activity, processes for preparingthem and their use as medicaments
11/08/2001	CA2405607A1 Pyrimidinyl methyl indole derivatives with antibacterial activity
11/07/2001	EP1150979A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
11/07/2001	EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
11/07/2001	EP1150970A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
11/07/2001	EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
11/07/2001	EP1150953A1 Indole derivatives and their use as mcp-1 receptor antagonists
11/07/2001	EP0923565B1 Process for preparing paclitaxel
11/07/2001	EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
11/07/2001	EP0843673B1 One pot synthesis of 2-oxazolidinone derivatives
11/07/2001	EP0776322B1 Method for the preparation of taxol and its derivatives
11/07/2001	EP0740660B1 Substituted oxazolines
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	EP0546108B1 Pro-drugs for cck antagonists
11/07/2001	CN1321156A Substd. isoxazolylthiophene compounds
11/07/2001	CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof
11/07/2001	CN1321152A Substd. oxazoles and thiazoles derivs. as hPPAR gamma and hPPAR alpha activators
11/07/2001	CN1321151A Chemical compounds
11/07/2001	CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001	CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use
11/07/2001	CN1320597A Antifungal and its preparation method and intermediate
11/07/2001	CN1074413C Novel benzimidazole derivs. having CGMP-phosphodisterase inhibiting activity
11/06/2001	US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy
11/06/2001	US6313308 Methods for the preparation of biphenyl isoxazole sulfonamides
11/06/2001	US6313307 Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
11/06/2001	US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001	US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis
11/06/2001	US6313147 For controlling phytopathogenic fungi
11/06/2001	US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001	US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001	US6313115 Alleviate impairment of memory, or other cognitive functions caused by hypoglutamatergic condition or by deficiency in number or strength of excitatory synapses or in number of ampa receptors
11/06/2001	US6313114 3,4-Dihydro-2H-benzo[1,4]oxazinyl-methyl)-[3-(1H-indol-3yl)-alkyl]- amines
11/06/2001	US6313113 Azolidinedione derivatives, analogues, tautomeric forms, stereoisomers, polymorphs, salts and solvates; treating non-insulin-dependent diabetes mellitus
11/06/2001	CA2193178C Matrix metalloprotease inhibitors
11/06/2001	CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole
11/01/2001	WO2001081350A1 Oxazolidinone derivatives with antibiotic activity
11/01/2001	WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
11/01/2001	WO2001081341A2 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
11/01/2001	WO2001081340A2 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	WO2001081338A1 Substituted sulfonylaminopyrimidines
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081335A1 Pyrimidine-sulfonamides having endothelin-antagonist activity
11/01/2001	WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
11/01/2001	WO2001081328A2 Thiazolidinedione analogues and their use for the treatment of diabetes
11/01/2001	WO2001081324A1 Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties
11/01/2001	WO2001081322A1 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
11/01/2001	WO2001081318A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001	WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
11/01/2001	WO2001080844A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
11/01/2001	WO2001080841A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
11/01/2001	WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
11/01/2001	WO2001034582A3 Sordaricin derivatives having antifungal activity
11/01/2001	WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036956 Estrogen receptor modulators
11/01/2001	US20010036946 Antiinflammatory agents
11/01/2001	CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001	CA2407093A1 Substituted phenyl farnesyltransferase inhibitors

1 ... 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 ... 647